LVW Advisors LLC lessened its holdings in shares of Relx Plc (NYSE:RELX – Free Report) by 4.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,930 shares of the technology company’s stock after selling 624 shares during the quarter. LVW Advisors LLC’s holdings in Relx were worth $587,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in the stock. Benjamin F. Edwards & Company Inc. increased its position in Relx by 5.7% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 7,422 shares of the technology company’s stock valued at $341,000 after acquiring an additional 403 shares during the last quarter. Profund Advisors LLC increased its stake in shares of Relx by 3.0% during the second quarter. Profund Advisors LLC now owns 14,007 shares of the technology company’s stock valued at $643,000 after buying an additional 407 shares during the period. Frank Rimerman Advisors LLC purchased a new position in Relx during the 2nd quarter valued at about $470,000. Evergreen Capital Management LLC lifted its holdings in Relx by 3.8% during the second quarter. Evergreen Capital Management LLC now owns 14,204 shares of the technology company’s stock worth $652,000 after buying an additional 517 shares during the period. Finally, Marietta Investment Partners LLC bought a new stake in Relx during the second quarter valued at about $206,000. 15.02% of the stock is owned by hedge funds and other institutional investors.
Relx Price Performance
RELX opened at $48.18 on Tuesday. The company’s 50 day simple moving average is $46.44 and its two-hundred day simple moving average is $46.59. Relx Plc has a 1-year low of $40.25 and a 1-year high of $48.91.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on Relx
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- 3 Warren Buffett Stocks to Buy Now
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What is a Dividend King?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.